Retatrutide is an investigational molecule. It is not an approved medicine in India, the UAE, or any other country, and it cannot be legally sold for human use. India status · UAE status

About

About This Resource

An independent record of what the published evidence on retatrutide actually says — written for readers in India and the United Arab Emirates.

Why this site exists

Retatrutide generates enormous search interest in India and the UAE. Most of what currently ranks for those searches is published by companies selling peptides — and they cannot answer the most important questions honestly, because the honest answers are that the molecule is approved nowhere, cannot lawfully be sold, and has no legitimate price.

That leaves a real gap: a resource that reports the science accurately, states the regulatory position plainly, and sells nothing. That is what this site is.

What we do

  • Track every registered retatrutide study and report what each is designed to answer.
  • Report trial results with the population, duration and estimand attached to every figure.
  • Document regulatory status in India and the UAE against primary sources — including, explicitly, what we could not verify.
  • Explain the research methods needed to read this evidence: estimands, endpoints, multiplicity, confidence intervals.
  • Say plainly when the evidence does not answer a question.

What we do not do

Clear limits

  • We do not sell, supply, source or broker any product, and never will.
  • We do not publish dosing guidance, dose calculators or administration instructions.
  • We do not provide medical advice or answer questions about your own health.
  • We do not recruit for clinical trials or make referrals.
  • We do not accept advertising or affiliate arrangements from peptide vendors.
  • We do not claim affiliation with Eli Lilly, any regulator, or any journal.

Our standards, in short

1

Primary sources first

Every claim traces to a peer-reviewed paper, a registry record, a regulatory source or the developer's own announcement — labelled by tier.

2

Uncertainty stated

Where we could not verify something, we say so. An empty search result is reported as exactly that, not as a conclusion.

3

No invented authority

No fabricated authors, reviewers, credentials or affiliations. We would rather carry no byline than a false one.

4

Dates on everything

Every time-sensitive statement carries its verification date, which moves only when a source is actually rechecked.

Infographic on trusted information resources: in-depth articles, clinical trial summaries, expert commentary, research updates and FAQs.
The kinds of material this resource maintains.

What we are not

We do not have a verified medical review board, and we do not pretend to. We are not clinicians, and nothing here substitutes for professional medical advice. What we offer instead is careful sourcing and a direct link to the primary record behind every claim — so you never have to take our word for anything.

Contact

Questions about the published evidence, and corrections, are welcome.

retatrutideindia@gmail.com
+1 (672) 273-0635